Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
about
The novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.A phase II dose-escalation trial of perioperative desmopressin (1-desamino-8-d-arginine vasopressin) in breast cancer patients.Vasopressin: the missing link for preeclampsia?Peptide Agonists of Vasopressin V2 Receptor Reduce Expression of Neuroendocrine Markers and Tumor Growth in Human Lung and Prostate Tumor CellsRegression of Walker 256 carcinosarcoma in vasopressin-deficient Brattleboro rats is accompanied by a changed laminin pattern.Addition of vasopressin synthetic analogue [V(4)Q(5)]dDAVP to standard chemotherapy enhances tumour growth inhibition and impairs metastatic spread in aggressive breast tumour models.
P2860
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
@en
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
@nl
type
label
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
@en
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
@nl
prefLabel
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
@en
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model.
@nl
P2093
P2860
P50
P1476
Reduction of tumor angiogenesis induced by desmopressin in a breast cancer model
@en
P2093
Giselle V Ripoll
Hernan G Farina
Marina Pifano
P2860
P2888
P356
10.1007/S10549-013-2724-6
P407
P577
2013-11-01T00:00:00Z